| Penile Carcinoma studied in …STUDIED_INderived44 of 44show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808359Phase 2 · not yet recruiting Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815197Phase 2 · not yet recruiting Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305654Phase 3 · active not recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma, Usual Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767266Phase 2 · not yet recruiting Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04718584Phase 2 · completed the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07110038Phase 2 · recruiting DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104618Phase 2 · recruiting Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260023Phase 1/Phase 2 · active not recruiting Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353906Phase 2 · recruiting Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526989Phase 2 · recruiting Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996849terminated Contemporary Characteristics of Penile Cancer · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999396Phase 1 · recruiting FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02104063completed Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET] · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06505551Phase 1/Phase 2 · not yet recruiting Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03439085Phase 2 · terminated DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224740Phase 2 · completed Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05787535Phase 1 · unknown HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05952947Phase 1 · recruiting HRYZ-T101 Injection for HPV18 Positive Solid Tumor · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068998completed Molecular Characterization of Penile Cancers in Developing Countries · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774901Phase 2 · unknown Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517488Phase 1 · completed A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02837042Phase 2 · terminated Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03221400Phase 1/Phase 2 · unknown PEN-866 in Patients With Advanced Solid Malignancies · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943602Phase 2 · unknown Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02541903Phase 2 · terminated Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807546Phase 2 · completed Oral Rigosertib for Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02279576Phase 2 · terminated Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) · condition mapped CURATED_BROADER · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02014831Phase 2 · withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) · condition mapped ALIAS · 44 trials mapped (25 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526486NA · completed Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer · condition mapped ONTOLOGY_EXACT · 44 trials mapped (25 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |